Pharvaris N.V. (PHVS)

NASDAQ: PHVS · IEX Real-Time Price · USD
23.36
-0.14 (-0.60%)
Mar 28, 2024, 12:23 PM EDT - Market open

Total Valuation

Pharvaris has a market cap or net worth of $1.26 billion. The enterprise value is $1.09 billion.

Market Cap 1.26B
Enterprise Value 1.09B

Important Dates

The next estimated earnings date is Monday, May 6, 2024, before market open.

Earnings Date May 6, 2024
Ex-Dividend Date n/a

Share Statistics

Pharvaris has 40.86 million shares outstanding. The number of shares has increased by 20.90% in one year.

Shares Outstanding 40.86M
Shares Change (YoY) +20.90%
Shares Change (QoQ) +20.67%
Owned by Insiders (%) 6.25%
Owned by Institutions (%) 85.94%
Float 16.76M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 7.66
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

Current Ratio n/a
Quick Ratio n/a
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 8.38

Financial Efficiency

Return on equity (ROE) is -70.90% and return on invested capital (ROIC) is -60.81%.

Return on Equity (ROE) -70.90%
Return on Assets (ROA) -63.60%
Return on Capital (ROIC) -60.81%
Revenue Per Employee n/a
Profits Per Employee -$1.76M
Employee Count 65
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Pharvaris has paid $651,208 in taxes.

Income Tax 651,208
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +216.71% in the last 52 weeks. The beta is -3.11, so Pharvaris's price volatility has been lower than the market average.

Beta (1Y) -3.11
52-Week Price Change +216.71%
50-Day Moving Average 26.71
200-Day Moving Average 21.06
Relative Strength Index (RSI) 44.81
Average Volume (30 Days) 111,103

Short Selling Information

The latest short interest is 14,883, so 0.04% of the outstanding shares have been sold short.

Short Interest 14,883
Short Previous Month 101,557
Short % of Shares Out 0.04%
Short % of Float 0.09%
Short Ratio (days to cover) 0.91

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -100.54M
Pretax Income -115.00M
Net Income -114.17M
EBITDA -130.33M
EBIT -130.59M
Earnings Per Share (EPS) -$3.28
Full Income Statement

Balance Sheet

The company has $170.65 million in cash and $313,960 in debt, giving a net cash position of $170.34 million or $4.17 per share.

Cash & Cash Equivalents 170.65M
Total Debt 313,960
Net Cash 170.34M
Net Cash Per Share $4.17
Equity / Book Value 165.01M
Book Value Per Share 4.04
Working Capital n/a
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$96.61 million and capital expenditures -$91,859, giving a free cash flow of -$96.70 million.

Operating Cash Flow -96.61M
Capital Expenditures -91,859
Free Cash Flow -96.70M
FCF Per Share -$2.37
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Pharvaris does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -20.90%
Shareholder Yield -20.90%
Earnings Yield -9.03%
FCF Yield -7.65%

Analyst Forecast

The average price target for Pharvaris is $31.67, which is 35.57% higher than the current price. The consensus rating is "Buy".

Price Target $31.67
Price Target Difference 35.57%
Analyst Consensus Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1